Antibiotics known as fluoroquinolones can make RNA interference more effective.

MIND researchers discover new insights into transcriptional dysregulation in HD.

Neurosearch will begin recruiting for the trial later this year.

The University of Iowa is recruiting participants for two important new studies.

Dimebon was found to be safe and well tolerated and there are indications of effectiveness.

An intracellular antibody which targets the HD protein in the cytoplasm of the cell ameliorates motor symptoms in the HD mice.

Here's an overview of some of the more promising potential treatments moving through the research pipeline.

By changing one amino acid, University of Florida researchers have increased the efficiency of an AAV vector for gene therapy.

Emory University researchers have developed a new primate model of HD to study the disease and potential treatments.

Indiana researchers hope that examining the structure of huntingtin interacting proteins will uncover new information about HD.